Avai Bio (AVAI) Long-Term Deferred Tax (2020 - 2026)

Avai Bio (AVAI) has 5 years of Long-Term Deferred Tax data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 70.08% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 70.08% YoY), and the FY2026 full-year result was $1.2 million, down 70.08% from the prior year.
• Long-Term Deferred Tax fell to $1.2 million in Q1 2026, from $4.1 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 million in Q1 2025 to a low of $847920.0 in Q1 2023.
• A 4-year average of $2.3 million and a median of $2.1 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax jumped 251.02% in 2024 and plunged 70.08% in 2026, its largest moves.
• Tracing AVAI's Long-Term Deferred Tax over 4 years: stood at $847920.0 in 2023, then jumped by 251.02% to $3.0 million in 2024, then surged by 38.37% to $4.1 million in 2025, then plunged by 70.08% to $1.2 million in 2026.
• Business Quant data shows AVAI's Long-Term Deferred Tax at $1.2 million in Q1 2026, $4.1 million in Q1 2025, and $3.0 million in Q1 2024.